Literature DB >> 7579356

Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23).

J M Hilden1, J L Frestedt, R O Moore, N A Heerema, D C Arthur, G H Reaman, J H Kersey.   

Abstract

Molecular techniques to detect MLL (11q23) and AF-4 (4q21) gene rearrangements are being evaluated for use in stratification of patients into prognostic groups. We studied 15 cases of infant acute lymphoblastic leukemia (ALL) with Southern blotting for MLL gene rearrangement and reverse transcriptase-polymerase chain reaction (RT-PCR) for t(4;11) fusion transcripts and compared the results to cytogenetic and clinical data. Our results indicate that classic t(4;11)(q21;q23) translocations are detected by RT-PCR; however, unusual 4;11 translocations still require additional investigation. We also extended and updated our original study of MLL gene rearrangement in infant ALL to 40 patients with longer follow-up and show that the group with germline configuration of the MLL gene continues to have an excellent outcome. The results of salvage therapy (bone marrow transplantation or chemotherapy) suggest that transplant may show advantage. Preliminary results of the use of RT-PCR to assess minimal disease are also reported.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579356

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).

Authors:  ZoAnn E Dreyer; Joanne M Hilden; Tamekia L Jones; Meenakshi Devidas; Naomi J Winick; Cheryl L Willman; Richard C Harvey; I-Ming Chen; Fred G Behm; Jeanette Pullen; Brent L Wood; Andrew J Carroll; Nyla A Heerema; Carolyn A Felix; Blaine Robinson; Gregory H Reaman; Wanda L Salzer; Stephen P Hunger; William L Carroll; Bruce M Camitta
Journal:  Pediatr Blood Cancer       Date:  2014-11-14       Impact factor: 3.167

2.  Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.

Authors:  Jean E Sanders; Ho Joon Im; Paul A Hoffmeister; Ted A Gooley; Ann E Woolfrey; Paul A Carpenter; Robert G Andrews; Eileen M Bryant; Frederick R Appelbaum
Journal:  Blood       Date:  2005-01-06       Impact factor: 22.113

3.  Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

Authors:  Joanne M Hilden; Patricia A Dinndorf; Sharon O Meerbaum; Harland Sather; Doojduen Villaluna; Nyla A Heerema; Ron McGlennen; Franklin O Smith; William G Woods; Wanda L Salzer; Helen S Johnstone; Zoann Dreyer; Gregory H Reaman
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

4.  Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis.

Authors:  Md Jobayer Hossain; Li Xie; Suzanne M McCahan
Journal:  J Cancer Epidemiol       Date:  2014-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.